113 related articles for article (PubMed ID: 10617142)
1. Ligand-receptor interactions as controlled by wild-type and mutant Thr(370)Lys alpha2B-adrenoceptor-Galpha15 fusion proteins.
Pauwels PJ; Tardif S; Finana F; Wurch T; Colpaert FC
J Neurochem; 2000 Jan; 74(1):375-84. PubMed ID: 10617142
[TBL] [Abstract][Full Text] [Related]
2. Analysis of ligand activation of alpha 2-adrenoceptor subtypes under conditions of equal G alpha protein stoichiometry.
Pauwels PJ; Wurch T; Tardif S; Finana F; Colpaert FC
Naunyn Schmiedebergs Arch Pharmacol; 2001 May; 363(5):526-36. PubMed ID: 11383713
[TBL] [Abstract][Full Text] [Related]
3. Facilitation of constitutive alpha(2A)-adrenoceptor activity by both single amino acid mutation (Thr(373)Lys) and g(alphao) protein coexpression: evidence for inverse agonism.
Pauwels PJ; Tardif S; Wurch T; Colpaert FC
J Pharmacol Exp Ther; 2000 Feb; 292(2):654-63. PubMed ID: 10640303
[TBL] [Abstract][Full Text] [Related]
4. Partial to complete antagonism by putative antagonists at the wild-type alpha(2C)-adrenoceptor based on kinetic analyses of agonist:antagonist interactions.
Pauwels PJ; Colpaert FC
Br J Pharmacol; 2000 Dec; 131(7):1385-90. PubMed ID: 11090111
[TBL] [Abstract][Full Text] [Related]
5. Disparate ligand-mediated Ca(2+) responses by wild-type, mutant Ser(200)Ala and Ser(204)Ala alpha(2A)-adrenoceptor: G(alpha15) fusion proteins: evidence for multiple ligand-activation binding sites.
Pauwels PJ; Colpaert FC
Br J Pharmacol; 2000 Aug; 130(7):1505-12. PubMed ID: 10928951
[TBL] [Abstract][Full Text] [Related]
6. Modulation of ligand responses by coupling of alpha(2A)-adrenoceptors to diverse G(alpha)-proteins.
Pauwels PJ; Tardif S; Colpaert FC; Wurch T
Biochem Pharmacol; 2001 May; 61(9):1079-92. PubMed ID: 11301041
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneous ligand-mediated Ca(++) responses at wt and mutant alpha(2A)-adrenoceptors suggest multiple ligand activation binding sites at the alpha(2A)-adrenoceptor.
Pauwels PJ; Colpaert FC
Neuropharmacology; 2000 Aug; 39(11):2101-11. PubMed ID: 10963753
[TBL] [Abstract][Full Text] [Related]
8. Agonist efficacy at the alpha2A-adrenoceptor:G alpha15 fusion protein: an analysis based on Ca2+ responses.
Pauwels PJ; Finana F; Tardif S; Colpaert FC; Wurch T
Naunyn Schmiedebergs Arch Pharmacol; 2000 Jun; 361(6):672-9. PubMed ID: 10882043
[TBL] [Abstract][Full Text] [Related]
9. Enhanced stability of wild-type and constitutively active alpha(2A)-adrenoceptors by ligands with agonist, silent and inverse agonist properties.
Pauwels PJ; Tardif S
Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):134-41. PubMed ID: 12122500
[TBL] [Abstract][Full Text] [Related]
10. Dissimilar pharmacological responses by a new series of imidazoline derivatives at precoupled and ligand-activated alpha 2A-adrenoceptor states: evidence for effector pathway-dependent differential antagonism.
Pauwels PJ; Rauly I; Wurch T
J Pharmacol Exp Ther; 2003 Jun; 305(3):1015-23. PubMed ID: 12649300
[TBL] [Abstract][Full Text] [Related]
11. G-protein activation by putative antagonists at mutant Thr373Lys alpha2A adrenergic receptors.
Wurch T; Colpaert FC; Pauwels PJ
Br J Pharmacol; 1999 Feb; 126(4):939-48. PubMed ID: 10193774
[TBL] [Abstract][Full Text] [Related]
12. Evidence for protean agonism of RX 831003 at alpha 2A-adrenoceptors by co-expression with different G alpha protein subunits.
Pauwels PJ; Rauly I; Wurch T; Colpaert FC
Neuropharmacology; 2002 May; 42(6):855-63. PubMed ID: 12015212
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of beta(2)-adrenoceptor coupling to G(s)-, G(i)-, and G(q)-proteins.
Wenzel-Seifert K; Seifert R
Mol Pharmacol; 2000 Nov; 58(5):954-66. PubMed ID: 11040042
[TBL] [Abstract][Full Text] [Related]
14. Activation of constitutive 5-hydroxytryptamine(1B) receptor by a series of mutations in the BBXXB motif: positioning of the third intracellular loop distal junction and its G(o)alpha protein interactions.
Pauwels PJ; Gouble A; Wurch T
Biochem J; 1999 Oct; 343 Pt 2(Pt 2):435-42. PubMed ID: 10510311
[TBL] [Abstract][Full Text] [Related]
15. Measurement of agonist-dependent and -independent signal initiation of alpha(1b)-adrenoceptor mutants by direct analysis of guanine nucleotide exchange on the G protein galpha(11).
Carrillo JJ; Stevens PA; Milligan G
J Pharmacol Exp Ther; 2002 Sep; 302(3):1080-8. PubMed ID: 12183666
[TBL] [Abstract][Full Text] [Related]
16. Differential activation of Gq/11 and Gi(3) proteins at 5-hydroxytryptamine(2C) receptors revealed by antibody capture assays: influence of receptor reserve and relationship to agonist-directed trafficking.
Cussac D; Newman-Tancredi A; Duqueyroix D; Pasteau V; Millan MJ
Mol Pharmacol; 2002 Sep; 62(3):578-89. PubMed ID: 12181434
[TBL] [Abstract][Full Text] [Related]
17. Intracellularly truncated human alpha2B-adrenoceptors: stable and functional GPCRs for structural studies.
Jaakola VP; Vainio M; Sen S; Rehn M; Heimo H; Scheinin M; Goldman A
J Recept Signal Transduct Res; 2005; 25(2):99-124. PubMed ID: 16149769
[TBL] [Abstract][Full Text] [Related]
18. Differential signalling of both wild-type and Thr(343)Arg dopamine D(2short) receptor by partial agonists in a G-protein-dependent manner.
Pauwels PJ; Tardif S; Colpaert FC
Biochem Pharmacol; 2001 Sep; 62(6):723-32. PubMed ID: 11551517
[TBL] [Abstract][Full Text] [Related]
19. Modulation of 5-HT1A receptor signalling by point-mutation of cysteine351 in the rat Galpha(o) protein.
Dupuis DS; Tardif S; Wurch T; Colpaert FC; Pauwels PJ
Neuropharmacology; 1999 Jul; 38(7):1035-41. PubMed ID: 10428422
[TBL] [Abstract][Full Text] [Related]
20. Subtype-specific stimulation of [35S]GTPgammaS binding by recombinant alpha2-adrenoceptors.
Peltonen JM; Pihlavisto M; Scheinin M
Eur J Pharmacol; 1998 Aug; 355(2-3):275-9. PubMed ID: 9760042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
